Research ArticleBasic Science Investigation
Two-Step Targeting and Dosimetry for Small Cell Lung Cancer Xenograft with Anti-NCAM/Antihistamine Bispecific Antibody and Radioiodinated Bivalent Hapten
Makoto Hosono, Masako N. Hosono, Françoise Kraeber-Bodéré, Anne Devys, Philippe Thédrez, Alain Faivre-Chauvet, Emmanuel Gautherot, Jacques Barbet and Jean-François Chatal
Journal of Nuclear Medicine July 1999, 40 (7) 1216-1221;
Makoto Hosono
Masako N. Hosono
Françoise Kraeber-Bodéré
Anne Devys
Philippe Thédrez
Alain Faivre-Chauvet
Emmanuel Gautherot
Jacques Barbet
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Two-Step Targeting and Dosimetry for Small Cell Lung Cancer Xenograft with Anti-NCAM/Antihistamine Bispecific Antibody and Radioiodinated Bivalent Hapten
Makoto Hosono, Masako N. Hosono, Françoise Kraeber-Bodéré, Anne Devys, Philippe Thédrez, Alain Faivre-Chauvet, Emmanuel Gautherot, Jacques Barbet, Jean-François Chatal
Journal of Nuclear Medicine Jul 1999, 40 (7) 1216-1221;
Two-Step Targeting and Dosimetry for Small Cell Lung Cancer Xenograft with Anti-NCAM/Antihistamine Bispecific Antibody and Radioiodinated Bivalent Hapten
Makoto Hosono, Masako N. Hosono, Françoise Kraeber-Bodéré, Anne Devys, Philippe Thédrez, Alain Faivre-Chauvet, Emmanuel Gautherot, Jacques Barbet, Jean-François Chatal
Journal of Nuclear Medicine Jul 1999, 40 (7) 1216-1221;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Transcriptional Gene Expression Profiling of Small Cell Lung Cancer Cells
- Pretargeted Radioimmunotherapy of Cancer: Progress Step by Step
- A Universal Pretargeting System for Cancer Detection and Therapy Using Bispecific Antibody
- Molecular Advances in Pretargeting Radioimunotherapy with Bispecific Antibodies
- Two-Step Targeting of Xenografted Colon Carcinoma Using a Bispecific Antibody and 188Re-Labeled Bivalent Hapten: Biodistribution and Dosimetry Studies